There is a syndrome consisting of acute infarction-like symptoms and ECG findings, and transient left ventricular apical ballooning without epicardial coronary artery obstruction. A 67-year-old female admitted to our hospital because of severe anterior chest pain was diagnosed as having this syndrome. Since stenotic, spastic, or occlusive sites were not found in epicardial coronary arteries by emergency cardiac catheterization, we speculated coronary microvasculature involvement in the pathophysiology of the event. Four weeks later in a drug-free condition, there was no significant epicardial coronary vasospasm by intracoronary acetylcholine administration (IC-ACh). The average peak flow velocity (APFV) of the left coronary artery (LCA) was measured using the Doppler flow wire method. Under maximal dilatation of the epicardial LCA by intracoronary nitroglycerin administration, IC-ACh was again performed taking into consideration that the change in APFV in response to IC-ACh reflects a coronary microvascular response to it. In the nonischemic control subjects, basal APFV increased to 296 ± 29% (n = 24) of the basal value after IC-ACh. In this patient, although IC-ACh did not cause vasospasm in epicardial LCA, APFV was decreased to 54% of its basal value. After administration of a Ca antagonist and KATP opener, she had no chest symptoms and was discharged from the hospital. In 2003, she forgot to take her medication for 3 days and then experienced a sudden recurrence of the same type of attack. She started her medication again and her symptoms disappeared. Three weeks later, she underwent an assessment of the coronary microvascular response to ACh with medicine. Her APFV after ACh increased to 177% of the basal value. (Int Heart J 2005; 1: 147-152) 
without coronary artery stenosis. The pathogeny of this phenomenon, which is sometimes called 'ampulla cardiomyopathy', has not been clarified 4) although catecholamine burden may be one of the causes in some patients. [1] [2] [3] 8) Since stenotic, spastic, or occlusive sites are not found in epicardial coronary arteries in such patients, involvement of the coronary microcirculation in the pathophysiology of this syndrome may be plausible. 4, 7) We experienced a female case who had recurrent chest pain attacks that were probably related to this syndrome. The clinical course and data for cardiac catheterization suggested the involvement of coronary microcirculatory disturbance in this patient's morbidity.
CASE REPORT
A 67-year-old female was admitted for the first time to our hospital in October 1999 because of severe anterior chest pain. On admission, ST segments on ECG were elevated in I, a V L , and V 2 through V 6 leads by 0.2-0.4 mV (Figure 1 ). The chest pain was not relieved with sublingual nitroglycerin. The patient underwent emergency cardiac catheterization due to a diagnosis of acute coronary syn- drome. Cineangiography showed no stenosis or obstruction in the right (data not shown) and left coronary arteries (left panel, Figure 2 ). Left ventriculography revealed akinesis in the apex, and severe asynergy in its surrounding area (right panel, Figure 2 ). Chest pain was relieved by intracoronary infusion of nitroglycerin and nicorandil, but continued to be mild for the next few hours. Creatine kinase (214 IU/L) and C-reactive protein (0.5 mg/dL) levels were mildly elevated 12 hours after admission. On the third hospital day, echocardiography documented the absence of wall motion abnormality. On ECG, ST elevation turned to deep negative T, but R waves did not decrease.
Since stenotic, spastic, or occlusive sites were not found in epicardial coronary arteries when the chest pain was lasting, we suspected coronary microvasculature involvement in the pathophysiology of this event. The patient received the second catheterization 4 weeks later. In this catheterization, there was no significant vasospasm in the epicardial coronary arteries due to the two to three doses of intracoronary acetylcholine (25, 50 and 100 µg for the left coronary artery, 25 and 50 µg for the right coronary artery, administration for 30 seconds each). Coronary microvascular function was then assessed. First, a Doppler flow wire was placed in the proximal portion of the large high lateral branch of the left coronary artery to measure the average peak flow velocity [APFV (cm/sec)] of the coronary artery. Second, by intracoronary nitroglycerin (2.5 mg bolus) administration, the epicardial portion of the left coronary artery was kept maximally dilated, following which acetylcholine (50 µg for 30 sec) was again administered into the coronary artery through the same guiding catheter. Thus, the change in APFV in response to intracoronary acetylcholine (IC-ACh) was considered to reflect the coronary microvascular response to it. In the nonischemic control subjects with
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Left ventriculography End-diastole End-systole chest pain (n = 24), we obtained data showing that basal APFV increased to 296 ± 29% of the basal value after IC-ACh (left panel, Figure 3 ). In this patient, although acetylcholine administration did not change the systemic blood pressure or heart rate, and cineangiography did not document vasospasm in epicardial coronary arteries, APFV decreased to 54% of its basal value (right upper panel, Figure 3) . Since these cardiac catheterization data suggested the involvement of coronary microvascular spasm, she was prescribed nifedipine (slow releasing type) 40 mg/day and nicorandil 15 mg/day. Although therapeutic prevention by drug administration for coronary microcirculatory impairment was not confirmed because she did not agree with the third catheterization while taking the medicine, she tolerated the drugs well, had no cardiac symptoms after that, and was discharged from our hospital.
She was followed-up with medical treatment in our outpatient clinic and no chest pain attacks were reported. However, in September 2003, she was admitted to our emergency room because of severe chest pain mimicking acute myocardial infarction like she experienced in 1999. It was found that she had forgotten to take her medicine for the past 3 days. Emergency cardiac catheterization (third catheterization for her) documented left ventricular apical ballooning on a left ventriculogram. However, neither coronary stenosis nor occlusion were revealed on cineangiograms, as in the case in 1999. Left ventricular endocardial myocardial biopsy revealed no evidence of acute myocarditis. Since these findings suggested that the transient diminished drug effect was the trigger of the recurrence of the attack, medical treatment with nefedipine and nicorandil at the doses mentioned above was started again, and she had no chest pain attacks thereafter. While continuing these medications, 3 weeks after the second attack, she underwent a fourth cardiac catheterization to assess whether the coronary microcirculatory spasm could be prevented by these drugs. Her APFV under pretreatment with intracoronary nitroglycerin increased to 177% of its basal value by intracoronary acethylcholine administration to the LCA. Thus, transient coronary microvascular spasm, which was supposed to have been induced by acethylcholine in the second catheterization in 1999, appeared to be prevented under the drug regimen. Although the increase in coronary flow reserve seemed to be still lower than that in the nonischemic control subjects as shown above, and since the medicines taken were all at maximal doses and her chest pain attacks were resolved by these drugs, she was discharged and is currently continuing these medications.
It is known that coronary microvascular spasm can mimic ischemic heart disease. 9) In the present study, intracoronary administration of acetylcholine under vasodilatation of the epicardial coronary artery with nitroglycerin reduced APFV without evoking epicardial coronary spasm, and without significant changes in cardiac demand or coronary perfusion pressure, suggesting that flow reduction in this coronary perfusion bed was due to coronary microvascular constriction by acetylcholine. The present patient had a recurrent attack 4 years after the first one. The second attack seems to be triggered by a failure of the patient to take her medication as directed. As shown by the results of the fourth catheterization, daily oral Ca antagonist and ATP-sensitive K channel opener administration at the maximal doses was likely to prevent the occurrence of acethylcholineinduced coronary microvasular spasm. Although it still remains to be determined whether this finding is common in the pathogeny of this syndrome, in this patient coronary microvascular spasm was thought to be involved in the pathophysiology of reversible ventricular dysfunction which mimicked acute coronary syndrome due to epicardial coronary artery disease.
In addition, coronary flow reserve was still low in this patient after restarting the medications compared to the nonischemic control subjects as mentioned above, and this patient's clinical course needs to be followed-up in the long-term carefully to assess whether the present medical treatments are adequate for managing this microvascular disorder.
